PlexusDx's Precision Peptide Genetic Test reveals these predispositions, supporting more informed conversations with your provider about which GLP-1 formulation and dosing strategy may align with your biology
Same number of units, different concentration, completely different dose
Semaglutide improves glycemic control, lowers fasting insulin, and enhances beta-cell function in people with or without diabetes. Overgaard et al., Diabetes, Obesity and Metabolism Cardiometabolic and Inflammatory Health Semaglutide may improve several key biomarkers: Lower LDL cholesterol and triglycerides Reduced blood pressure Decreased CRP and systemic inflammation This makes it useful not only for aesthetics, but also for long-term cardiovascular and metabolic protection
The steroidal MRAs spironolactone (first generation) and eplerenone (second generation) were the first to enter clinical practice and act as potassium-sparing diuretics with potent antihypertensive effects
PlexusDx complements either approach by offering compounded GLP-1 formulations and a Precision Peptide Genetic Test to help providers personalize dosing and formulation based on metabolic pathway variants
I have had amazing results in the care of Laura, the Nurse Practitioner